A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer. (Nanowerk Spotlight) Immune-based cancer ...
Scientists are always working to improve cancer treatment so that it’s quicker, safer and more effective for patients. And it seems researchers at the University of California-San Francisco have made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results